We are live on ! Find out more

ASP Isotopes

ASPI

Market cap $489M

3.19 USD

-0.12

3.63%

At close Updated Sep 14, 4:00 PM EDT

Pre-market

After hours

3.21

+0.02

0.63%

1 day

-3.63%

5 days

-25.64%

1 month

-25.29%

3 months

-51.96%

6 months

-40.26%

Year to date

-43.34%

1 year

-65.55%

5 years

19.48%

10 years

19.48%

About: ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Currently, the company has three operating segments: (i) nuclear fuels, (ii) specialist isotopes and related services, and (iii) construction services. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.

Employees: 271

Materials Specialty Chemicals

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 10.5%

Neutral 89.5%

Negative 0%

ASP Isotopes Inc. (ASPI) Analyst/Investor Day Transcript

ASP Isotopes Inc. (ASPI) Analyst/Investor Day Transcript

ASP Isotopes Inc. (ASPI) Analyst/Investor Day Transcript

ASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational Update

DALLAS, Sept. 08, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for critical materials production, today hosts its inaugural Capital Markets Day in London. Management will outline the Company's strategy across nuclear medicine, electronics, helium and LNG, and nuclear fuels, and will provide an overview of the building blocks supporting the Company's long-term growth potential.

ASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational Update

ASP Isotopes Nears Helium Production, Advances Stable Isotope Growth

ASP Isotopes NASDAQ: ASPI expects several of its business units to enter commercial production or expand output over the next six months, with Chief Executive Officer Paul Mann highlighting progress in helium, liquefied natural gas, stable isotopes and radiopharmaceuticals during a conference presentation.

ASP Isotopes Nears Helium Production, Advances Stable Isotope Growth

ASP Isotopes Inc. Announces that Renergen Limited's Subsidiary has Commenced Commissioning of Liquid Helium Plant in South Africa

Tetra4, a subsidiary of Renergen and the developer of the Virginia Gas Project, has started the commissioning phase of the Phase 1 Liquid Helium plant post engineering optimization The production is expected to be among the first new liquid helium supply to enter the market at a time of acute global shortage The Company remains on track to deliver liquid helium to customers during September and ramp production to nameplate capacity during 2H Following the successful start-up of Phase 1, the Company expects to advance to Phase 2 during 2H 2026. The Company is currently exploring ways to accelerate the revenues and cash flows from Phase 2 DALLAS, Aug. 20, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that Tetra4 Proprietary Limited, a subsidiary of Renergen Limited (“Renergen”) and the developer of the Virginia Gas Project, has entered the commissioning phase of the Company's liquid helium plant.

ASP Isotopes Inc. Announces that Renergen Limited's Subsidiary has Commenced Commissioning of Liquid Helium Plant in South Africa

ASP Isotopes Announces Quantum Leap Energy is Evaluating Metal Conversion Opportunities in Namibia

DALLAS, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that Quantum Leap Energy LLC (“we,” "QLE" or the "Company"), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, is evaluating metal conversion opportunities in Namibia. As part of this evaluation, a public environmental and social impact assessment and consultation process has commenced for a proposed pilot-scale hydrofluorination and fluorination facility in the Walvis Bay area of Namibia.

ASP Isotopes Announces Quantum Leap Energy is Evaluating Metal Conversion Opportunities in Namibia

ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASLD--ENDRA Life Sciences Inc. (NASDAQ: NDRA) (“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. Second Quarter 2026 and Recent Highlights On June 25, 2026, ENDRA entered into a definitive merger agreement with ASP Isotopes Inc. (NASDAQ: ASPI), Noble Africa LLC (“Noble Africa”) , R.

ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

ASP Isotopes Targets 2026 Deliveries as Helium, Radiopharmacy Expansion Gains Speed

ASP Isotopes NASDAQ: ASPI outlined plans to expand its isotope production, radiopharmacy and helium businesses during Canaccord Genuity's 46th Annual Growth Conference, with commercial deliveries of several stable isotopes targeted for the second half of 2026.

ASP Isotopes Targets 2026 Deliveries as Helium, Radiopharmacy Expansion Gains Speed

ASP Isotopes Inc. Announces that Renergen Limited's Subsidiary has Entered into a Take-or-Pay Contract for the Supply of Liquified Natural Gas to Be Produced at the Virginia Gas Project in South Africa

Tetra4, a subsidiary of Renergen and the developer of the Virginia Gas Project, has entered into an additional take-or-pay contract to supply liquified natural gas (LNG) to a domestic food processor, establishing a multi-year contracted cash flow supporting Phase 1 commercial operations, which remain targeted for completion in the third quarter of 2026

ASP Isotopes Inc. Announces that Renergen Limited's Subsidiary has Entered into a Take-or-Pay Contract for the Supply of Liquified Natural Gas to Be Produced at the Virginia Gas Project in South Africa

ASP Isotopes to Participate in Citi's 2026 Natural Resources Conference

DALLAS, Aug. 05, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that it will host investor meetings at Citi's 2026 Natural Resources Conference on Thursday, August 13, 2026, in Las Vegas, Nevada.

ASP Isotopes to Participate in Citi's 2026 Natural Resources Conference

Aeternum Health Announces Change in Strategy, New Management, and Updates Investors on Progress

Washington D.C., August 4, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aeternum Health (OTC: AETN) (“Company”), today announced a change in strategy, new management and provides investors with an update on corporate progress.

Aeternum Health Announces Change in Strategy, New Management, and Updates Investors on Progress

See News Rankings

Price charts implemented using Lightweight Charts™